Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.

Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper

    • Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Abstract Text:

    Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Publishing Authors By Initials

    For similar behavioral disciplines and activities: psychiatric status rating scales research abstracts see: behavioral disciplines and activities: psychiatric status rating scales research

    PUBMED ID PMID:

    MEDLINE DATE:

    Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Journal Published:

    PUBLICATION TYPE: Letter

    Journal: Psychiatry research

    VOLUME: 36

    Page Numbers: 333-5

    Journal Abbreviation: Psychiatry Res

    ISSN: 0165-1781

    DAY: 17

    MONTH: Mar

    YEAR: 1991

    Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7911385

    Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Keywords Mesh Terms:

    KEYWORDS: Psychiatric Status Rating Scales

    MESH TERMS: administration & dosage

    Chemical & Substance for Abstract: Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients. Information

    Substance Name: Lithium

    Registry Number: 7439-93-2

    Grant and Affiliation Information for Brofaromine vs. maprotiline plus lithium in treatment-resistant depressed outpatients.

    AFFILIATION:

    Country: IRELAND

    IRELAND Research PublicationIRELAND Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Psychiatry Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Brofaromine vs maprotiline plus lithium in treatment-resistant depressed outpatients Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News